Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite. / Mistarz, Ulrik H; Singh, Susheel K; Nguyen, Tam T T N; Roeffen, Will; Yang, Fen; Lissau, Casper; Madsen, Søren M; Vrang, Astrid; Tiendrebeogo, Régis W; Kana, Ikhlaq H; Sauerwein, Robert W; Theisen, Michael; Rand, Kasper D.

In: Pharmaceutical Research, Vol. 34, No. 9, 01.09.2017, p. 1970-1983.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Mistarz, UH, Singh, SK, Nguyen, TTTN, Roeffen, W, Yang, F, Lissau, C, Madsen, SM, Vrang, A, Tiendrebeogo, RW, Kana, IH, Sauerwein, RW, Theisen, M & Rand, KD 2017, 'Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite', Pharmaceutical Research, vol. 34, no. 9, pp. 1970-1983. https://doi.org/10.1007/s11095-017-2208-1

APA

Mistarz, U. H., Singh, S. K., Nguyen, T. T. T. N., Roeffen, W., Yang, F., Lissau, C., Madsen, S. M., Vrang, A., Tiendrebeogo, R. W., Kana, I. H., Sauerwein, R. W., Theisen, M., & Rand, K. D. (2017). Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite. Pharmaceutical Research, 34(9), 1970-1983. https://doi.org/10.1007/s11095-017-2208-1

Vancouver

Mistarz UH, Singh SK, Nguyen TTTN, Roeffen W, Yang F, Lissau C et al. Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite. Pharmaceutical Research. 2017 Sep 1;34(9):1970-1983. https://doi.org/10.1007/s11095-017-2208-1

Author

Mistarz, Ulrik H ; Singh, Susheel K ; Nguyen, Tam T T N ; Roeffen, Will ; Yang, Fen ; Lissau, Casper ; Madsen, Søren M ; Vrang, Astrid ; Tiendrebeogo, Régis W ; Kana, Ikhlaq H ; Sauerwein, Robert W ; Theisen, Michael ; Rand, Kasper D. / Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite. In: Pharmaceutical Research. 2017 ; Vol. 34, No. 9. pp. 1970-1983.

Bibtex

@article{87c7b45d65434b0daebe8309401b3350,
title = "Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite",
abstract = "PURPOSE: Production and characterization of a chimeric fusion protein (GMZ2'.10C) which combines epitopes of key malaria parasite antigens: glutamate-rich protein (GLURP), merozoite surface protein 3 (MSP3), and the highly disulphide bonded Pfs48/45 (10C). GMZ2'.10C is a potential candidate for a multi-stage malaria vaccine that targets both transmission and asexual life-cycle stages of the parasite.METHODS: GMZ2'.10C was produced in Lactococcus lactis and purified using either an immunoaffinity purification (IP) or a conventional purification (CP) method. Protein purity and stability was analysed by RP-HPLC, SEC-HPLC, 2-site ELISA, gel-electrophoresis and Western blotting. Structural characterization (mass analysis, peptide mapping and cysteine connectivity mapping) was performed by LC-MS/MS.RESULTS: CP-GMZ2'.10C resulted in similar purity, yield, structure and stability as compared to IP-GMZ2'.10C. CP-GMZ2'.10C and IP-GMZ2'.10C both elicited a high titer of transmission blocking (TB) antibodies in rodents. The intricate disulphide-bond connectivity of C-terminus Pfs48/45 was analysed by tandem mass spectrometry and was established for GMZ2'.10C and two reference fusion proteins encompassing similar parts of Pfs48/45.CONCLUSION: GMZ2'.10C, combining GMZ2' and correctly-folded Pfs48/45 can be produced by the Lactoccus lactis P170 based expression system in purity and quality for pharmaceutical development and elicit high level of TB antibodies. The cysteine connectivity for the 10C region of Pfs48/45 was revealed experimentally, providing an important guideline for employing the Pfs48/45 antigen in vaccine design.",
keywords = "Malaria Vaccine, Mass spectrometry, Disulphide bond mapping, Biopharmaceuticals",
author = "Mistarz, {Ulrik H} and Singh, {Susheel K} and Nguyen, {Tam T T N} and Will Roeffen and Fen Yang and Casper Lissau and Madsen, {S{\o}ren M} and Astrid Vrang and Tiendrebeogo, {R{\'e}gis W} and Kana, {Ikhlaq H} and Sauerwein, {Robert W} and Michael Theisen and Rand, {Kasper D}",
year = "2017",
month = sep,
day = "1",
doi = "10.1007/s11095-017-2208-1",
language = "English",
volume = "34",
pages = "1970--1983",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer",
number = "9",

}

RIS

TY - JOUR

T1 - Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite

AU - Mistarz, Ulrik H

AU - Singh, Susheel K

AU - Nguyen, Tam T T N

AU - Roeffen, Will

AU - Yang, Fen

AU - Lissau, Casper

AU - Madsen, Søren M

AU - Vrang, Astrid

AU - Tiendrebeogo, Régis W

AU - Kana, Ikhlaq H

AU - Sauerwein, Robert W

AU - Theisen, Michael

AU - Rand, Kasper D

PY - 2017/9/1

Y1 - 2017/9/1

N2 - PURPOSE: Production and characterization of a chimeric fusion protein (GMZ2'.10C) which combines epitopes of key malaria parasite antigens: glutamate-rich protein (GLURP), merozoite surface protein 3 (MSP3), and the highly disulphide bonded Pfs48/45 (10C). GMZ2'.10C is a potential candidate for a multi-stage malaria vaccine that targets both transmission and asexual life-cycle stages of the parasite.METHODS: GMZ2'.10C was produced in Lactococcus lactis and purified using either an immunoaffinity purification (IP) or a conventional purification (CP) method. Protein purity and stability was analysed by RP-HPLC, SEC-HPLC, 2-site ELISA, gel-electrophoresis and Western blotting. Structural characterization (mass analysis, peptide mapping and cysteine connectivity mapping) was performed by LC-MS/MS.RESULTS: CP-GMZ2'.10C resulted in similar purity, yield, structure and stability as compared to IP-GMZ2'.10C. CP-GMZ2'.10C and IP-GMZ2'.10C both elicited a high titer of transmission blocking (TB) antibodies in rodents. The intricate disulphide-bond connectivity of C-terminus Pfs48/45 was analysed by tandem mass spectrometry and was established for GMZ2'.10C and two reference fusion proteins encompassing similar parts of Pfs48/45.CONCLUSION: GMZ2'.10C, combining GMZ2' and correctly-folded Pfs48/45 can be produced by the Lactoccus lactis P170 based expression system in purity and quality for pharmaceutical development and elicit high level of TB antibodies. The cysteine connectivity for the 10C region of Pfs48/45 was revealed experimentally, providing an important guideline for employing the Pfs48/45 antigen in vaccine design.

AB - PURPOSE: Production and characterization of a chimeric fusion protein (GMZ2'.10C) which combines epitopes of key malaria parasite antigens: glutamate-rich protein (GLURP), merozoite surface protein 3 (MSP3), and the highly disulphide bonded Pfs48/45 (10C). GMZ2'.10C is a potential candidate for a multi-stage malaria vaccine that targets both transmission and asexual life-cycle stages of the parasite.METHODS: GMZ2'.10C was produced in Lactococcus lactis and purified using either an immunoaffinity purification (IP) or a conventional purification (CP) method. Protein purity and stability was analysed by RP-HPLC, SEC-HPLC, 2-site ELISA, gel-electrophoresis and Western blotting. Structural characterization (mass analysis, peptide mapping and cysteine connectivity mapping) was performed by LC-MS/MS.RESULTS: CP-GMZ2'.10C resulted in similar purity, yield, structure and stability as compared to IP-GMZ2'.10C. CP-GMZ2'.10C and IP-GMZ2'.10C both elicited a high titer of transmission blocking (TB) antibodies in rodents. The intricate disulphide-bond connectivity of C-terminus Pfs48/45 was analysed by tandem mass spectrometry and was established for GMZ2'.10C and two reference fusion proteins encompassing similar parts of Pfs48/45.CONCLUSION: GMZ2'.10C, combining GMZ2' and correctly-folded Pfs48/45 can be produced by the Lactoccus lactis P170 based expression system in purity and quality for pharmaceutical development and elicit high level of TB antibodies. The cysteine connectivity for the 10C region of Pfs48/45 was revealed experimentally, providing an important guideline for employing the Pfs48/45 antigen in vaccine design.

KW - Malaria Vaccine

KW - Mass spectrometry

KW - Disulphide bond mapping

KW - Biopharmaceuticals

U2 - 10.1007/s11095-017-2208-1

DO - 10.1007/s11095-017-2208-1

M3 - Journal article

C2 - 28646324

VL - 34

SP - 1970

EP - 1983

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 9

ER -

ID: 179921497